Navigation Links
Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review
Date:6/19/2013

Lexington, Mass. (PRWEB) June 19, 2013

Imprivata®, a leading global provider of healthcare IT security solutions, today announced that Imprivata OneSign® leads the single sign-on (SSO) category in the KLAS® 2013 Mid-Term Performance Review: Software & Services report. CIOs and other healthcare executives iwere nterviewed by KLAS laud Imprivata on the superior performance of its products and the quality of its customer service and support, and they indicate that Imprivata is integral to their long-term healthcare IT strategy.

“Imprivata is a strategic partner. The SSO product used in conjunction with smooth roaming creates an environment that is both efficient and highly valued by our users. Imprivata enables No Click Access™ to clinical systems and patient information that delivers both security and convenience that clinicians need to better focus on patient care,” said Bruce Hall, CIO of Augusta Health, a 255-bed hospital in Fisherville, Va. “In addition, Imprivata understands the evolving healthcare IT landscape. We expect Imprivata will remain central to our healthcare IT strategy over the long term.”

The KLAS 2013 Mid-Term Performance Review: Software & Services report profiles hundreds of software and services vendors, providing a detailed look at the performance of each company's product line. The report aggregates performance data gathered over the past 12 months. The findings represent the voice of thousands of providers sharing their candid experience with various healthcare technology and vendors. Imprivata OneSign received a score of 88.4, building on the company’s momentum from 2012 when it was recognized as the SSO category leader in the KLAS 2012 Top 20 Best in KLAS Awards report.

“KLAS rankings are derived directly from customer input, so our consistently high scores serve as strong independent validation of Imprivata’s products, customer service and strategic importance,” said Ed Gaudet, chief marketing officer of Imprivata. “Imprivata also has the highest U.S. market share among SSO providers, according to HIMSS Analytics data, which supports feedback that we regularly receive from customers—Imprivata is the most widely-used application in hospitals after the electronic medical records system. Imprivata is simplifying healthcare IT to enable our customers with better focus on patient care.”

About Imprivata
Imprivata, the leader in healthcare IT security, enables secure access and collaboration for two million healthcare users worldwide. As the #1 independent provider of single sign-on and access management solutions for healthcare and other regulated industries, Imprivata OneSign® Single Sign-On is exclusively endorsed by the American Hospital Association (AHA) and recognized by Gartner and KLAS. Imprivata Cortext™ is the leading free HIPAA compliant text messaging solution for healthcare. Headquartered in Lexington, Massachusetts, Imprivata serves 1,300 hospitals in partnership with over 200 EMR and technology infrastructure vendors around the world. For more information, please visit http://www.imprivata.com.

All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10848144.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. MEDITECH Customers According to HIMSS Analytics
2. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
3. Upstart Bachelorista Inc. Releases Tell-All Playbook For Single Women
4. Johns Hopkins surgeons among the first in the country to perform a robotic single-site hysterectomy
5. Talk Therapy Can Ease Depression, But No Single Type Deemed Best
6. LAPD Singles Out Narconon Drug Prevention and Education for Special Commendation
7. Northern Westchester Hospital Surgeon Reaches New Single-Incision Robot-Assisted Gallbladder Removal Surgery Milestone
8. Unique group for single fathers due to cancer offers support
9. Single Leg Deadlift Exercise Video Revealed By Bodyweight Torch
10. Single Concussion May Lead to Lasting Brain Damage
11. Single concussion may cause lasting brain damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... 2017 , ... Patients with missing teeth now have the ... from Dr. Alejandro Kovacs. Dr. Kovacs is a board-certified periodontist and prosthodontist who ... dental implants in Longview, TX. , During traditional dental implant ...
(Date:7/27/2017)... ... 27, 2017 , ... TransPanel Volume 4 is a collection of animating panel ... exclusive features transitions that contain between 2 and 6 animated panels. Change the direction ... menus. TransPanel Volume 4 makes editing easy in Final Cut Pro X. , TransPanel ...
(Date:7/27/2017)... Clara, CA (PRWEB) , ... July 27, 2017 ... ... announces the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution to ... support accelerated diagnostics and sleep care management. The speed and functionality of scoring ...
(Date:7/27/2017)... ... 2017 , ... SSCI, a division of Albany Molecular Research, ... representing a milestone achievement. , As an industry-leading provider of ... served as expert and fact witnesses to assist our clients to perform infringement ...
(Date:7/27/2017)... ... ... Angeles leg of the US movie premier of the Man in the Camo Jacket will ... Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the LA Live ... musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer and inspiring ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... July 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... its second quarter 2017 operating results on Monday, August ... to follow at 5:00 p.m. ET. ... to a live broadcast of the conference call by ... participant code 51641230 approximately 15 minutes prior to the ...
(Date:7/20/2017)... 2017  Prime Therapeutics LLC (Prime) released this statement from ... today,s Institute for Clinical and Economic Review,s (ICER) public ... and value of abuse-deterrent formulations (ADF) of opioids. Prime was ... the meeting. "The ... to the use of abuse-deterrent formulations (ADF) in opioids in ...
(Date:7/14/2017)... VEGAS , July 13, 2017 It should ... United States is in the midst of a ... Control , since 1999, the number of overdose deaths from ... "resulting in over half a million dead from 2001 to ... codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling ...
Breaking Medicine Technology: